PEG-interleukin-2

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

HUMAN INTERLEUKIN 2-POLYETHYLENE GLYCOL CONJUGATE AND USE THEREOF
- EP 4397677 A1
  申请人: NOVOCODEX BIOPHARMACEUTICALS CO LTD优先权: 2021
  CN
  EP
  US
  WO
  4 件公开
- US 20250213703 A1
  申请人: NOVOCODEX BIOPHARMACEUTICALS CO LTD优先权: 2021
  US
TREATMENT OF ATOPIC DERMATITIS WITH POLYETHYLENE GLYCOL-MODIFIED INTERLEUKIN 2, GLUCOCORTICOID AND HYALURONIC ACID
EP 4656202 A1申请人: XIE YANHUI优先权: 2023
CN
EP
US
WO
4 件公开
SITE-SPECIFIC COUPLED PEGYLATED INTERLEUKIN-2 MUTANT WITH RECEPTOR AFFINITY PREFERENCE AND USE THEREOF
EP 4631972 A1申请人: NANJING NOVOACINE BIOTECHNOLOGY CO LTD优先权: 2022
CN
EP
WO
3 件公开
MODIFIED IL-2 PROTEINS, PEG CONJUGATES, AND USES THEREOF
US 2022324932 A1申请人: CSPC MEGALITH BIOPHARMACEUTICAL CO LTD优先权: 2019
US
WO
3 件公开
Macrimmune V, a composition for treating cancer
US 2004086557 A1申请人: LIPTON JAMES S优先权: 2001
US
PEGylated soluble gp130-dimers useful as a medicament
EP 1491554 A1申请人: CONARIS RES INST AG优先权: 2003
EP
Method for producing human interleukin 6 by high-density fermentation
CN 101736009 B申请人: GUANGZHOU INST BIOMED & HEALTH优先权: 2009
CN
Glucocorticoid combined with polyethylene glycol-modified interleukin 2 for treating respiratory disease
US 10898576 B2申请人: XIE YANHUI优先权: 2016
US
Method for synthesizing IgA kidney disease-treating nanopreparation
CN 111450080 A申请人: UNIV TIANJIN优先权: 2020
CN
Synthesis method of Systemic Lupus Erythematosus (SLE) treatment nanoparticles
CN 111450082 A申请人: UNIV TIANJIN优先权: 2020
CN

药物

PEG-interleukin-2

专利

HUMAN INTERLEUKIN 2-POLYETHYLENE GLYCOL CONJUGATE AND USE THEREOF